The table below shows Day One Biopharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$103.76M
-$78.11M
-$146.85M
-$109.87M
-$48.54M
-$13.49M
Capital expenditure
$320.00K
$2.17M
$224.00K
$26.00K
$0.00
$92.00K
Investing cash flow
$174.65M
-$230.99M
$128.38M
-$255.07M
-$8.00M
-$92.00K
Dividends paid
-
-
-
-
DAWN operating cash flow (10-K history)
Day One Biopharmaceuticals, Inc. reported operating cash flow of -$103.76M for fiscal year 2025. That is down 32.8% from -$78.11M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$4.51M (FY 2019) to -$103.76M. Figures come from the company's audited annual reports as filed with the SEC.